Study of T900607-Sodium in Chemotherapy Naive Patients With Hepatocellular Carcinoma.
- Conditions
- Hepatocellular Carcinoma
- Registration Number
- NCT00043433
- Lead Sponsor
- Tularik
- Brief Summary
The purpose of the study is to determine whether T900607-sodium is effective and safe in treating hepatocellular carcinoma, a type of liver cancer.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 35
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (12)
Scripps Health Center
🇺🇸La Jolla, California, United States
University of California San Diego
🇺🇸La Jolla, California, United States
George Washington University
🇺🇸Washington, District of Columbia, United States
H. Lee Moffitt Cancer Center
🇺🇸Tampa, Florida, United States
Ellis Fischel Cancer Center
🇺🇸Columbia, Missouri, United States
University of New Mexico
🇺🇸Albuquerque, New Mexico, United States
University of Rochester
🇺🇸Rochester, New York, United States
Ireland Cancer Center
🇺🇸Cleveland, Ohio, United States
University of Pennsylvania
🇺🇸Philadelphia, Pennsylvania, United States
Fox Chase Cancer Center
🇺🇸Philadelphia, Pennsylvania, United States
Scroll for more (2 remaining)Scripps Health Center🇺🇸La Jolla, California, United States